ANRO R&D Expenses
Alto Neuroscience, Inc. Common Stock · R&D Expenses
ANRO R&D Expenses
Latest reported$22.11Mperiod ending
ANRO Quarterly R&D Expenses ($6.32M → $22.11M)
Quarterly R&D Expenses
High-resolution chart · PNG
ANRO r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 22,108,000 | |
| 20,294,000 | |
| 11,996,000 | |
| 10,525,000 | |
| 13,124,000 | |
| 9,974,000 | |
| 10,800,000 | |
| 13,060,000 | |
| 13,184,000 | |
| 9,952,000 | |
| 9,643,000 | |
| 7,967,000 | |
| 7,072,000 | |
| 5,609,000 | |
| 6,324,000 |